The Role of Registries and Tumor Banking in Rare Pediatric Tumors

Abstract

Rare pediatric tumors are a heterogenous group of tumors that are rare at any age, or rare in children and common in adults. These are orphan diseases which have not benefitted from the significant advances seen in other pediatric malignancies. To improve our understanding of these tumors, rare tumor registries and tissue repositories have been established. The development of registries has followed two different models: in Europe, the focus has been on large co-operative group registries that enroll the breath of rare tumors, while in the USA, individual rare tumor registries have predominated. Both types of registries have significantly improved our understanding of these tumors. The co-operative group registries have provided valuable information on some very rare tumors, leading to the development of therapeutic guidelines, with the goal of standardizing treatment. On the other hand, the individual rare tumor registries have focused on single tumors, providing granular clinical and molecular information. They have defined the molecular pathogenesis of these tumors and provided new models to understanding carcinogenesis. We discuss the important contributions made by these registries.

This is a preview of subscription content, log in to check access.

Fig. 1

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. 1.

    National Institutes of Health: Office of Rare Disease Research. Rare diseases and related terms. 2010. Available from: http://rarediseases.info.nih.gov/RareDiseaseList.aspx. Accessed 29 Jan 2010.

  2. 2.

    The European Parliament and the Council of Europe. Regulation (EC) No. 141/2000 of the European Parliament and of the Council of Europe of December 16,1999 on orphan medical products. Official Journal of the European Communities. 1999.

  3. 3.

    Ferrari A, Bisogno G, De Salvo GL, Indolfi P, et al. The challenge of very rare tumors in childhood: the Italian TREP project. Eur J Cancer. 2007;43:654–9.

    Article  PubMed  Google Scholar 

  4. 4.

    • Ferrari A, Schneider DT, Bisogno G; EXPeRT Board. The founding of the European Cooperative Study Group on Pediatric Rare Tumors–EXPeRT. Expert Rev Anticancer Ther. 2013;13(1):1–3. This article outlines the formation of the European Co-operative Study group on Pediatric Rare Tumors, and their definition of Pediatric Rare Tumors.

  5. 5.

    Childhood cancer by the ICCC. In: Howlader N, Noone AM, Krapcho M, et al. editors. SEER Cancer Statistics Review, 1975–2009 (Vintage 2009 Populations). Bethesda: National Cancer Institute. 2012. Section 29.

  6. 6.

    Pappo AS, Krailo M, Chen Z, Rodriguez-Galindo C, Reaman G. Infrequent Tumor Initiative of the Children’s Oncology Group: Initial lessons learned and their impact on future plans. J Clin Oncol. 2010;28:5011–6.

    Article  PubMed Central  PubMed  Google Scholar 

  7. 7.

    • Pashankar F, Rodriguez-Galindo C, Pappo A. Development of a therapeutic approach to rare cancers in children: The Children’s Oncology Group Experience. J Pediatr Hematol Oncol. 2012;34:S37–8. This article outlines the Initiatives of the Children’s Oncology Group, Rare Tumor Committee.

  8. 8.

    Pastore G, De Salvo GL, Bisogno G, Dama E, Inserra A, Cecchetto G, Ferrari A. Evaluating access to pediatric cancer care centers of children and adolescents with rare tumors in Italy: the TREP project. Pediatr Blood Cancer. 2009;53:152–5.

    Article  PubMed  Google Scholar 

  9. 9.

    Bisogno G, Cecchetto G. A ferrari very rare tumours in paediatric age—from ‘Tumori Rari in Età Pediatrica’to the European Cooperative Study Group for Paediatric Rare Tumours. Eur Oncol Haematol. 2012;8(2):130–4.

    Google Scholar 

  10. 10.

    Dall’igna P, Cecchetto G, Bisogno G, Conte M, Chiesa PL, D’Angelo P, De Leonardis F, De Salvo G, Favini F, Ferrari A, TREP Group. Pancreatic tumors in children and adolescents: the Italian TREP project experience. Pediatr Blood Cancer. 2010;54:675–80.

    PubMed  Google Scholar 

  11. 11.

    • Carretto E, Inserra A, Ferrari A, Conte M, Di Cataldo A, Migliorati R, Cecchetto G, Bisogno G. Epithelial thymic tumors in pediatric age: a report from the TREP project. Orphanet J Rare Dis. 2011;6:28. This article describes the clinical features and outcome of a very rare pediatric malignancy, highlighting the importance of co-operative group registries to better define these rare tumors.

  12. 12.

    • Bisogno G, Tagarelli A, Schiavetti A, Scarzello G, Ferrari A, Cecchetto G, Alaggio R. Myoepithelial carcinoma treatment in children: a report from the TREP project. Pediatr Blood Cancer. 2014;61:643–6. This article describes the clinical features and outcome of a very rare pediatric malignancy, highlighting the importance of co-operative group registries to better define these rare tumors.

  13. 13.

    Indolfi P, Bisogno G, Cecchetto G, Spreafico F, De Salvo GL, Collini P, Jenkner A, Inserra A, Schiavetti A, di Martino M, Casale F. Local lymph node involvement in pediatric renal cell carcinoma: a report from the Italian TREP project. Pediatr Blood Cancer. 2008;51:475–8.

    Article  PubMed  Google Scholar 

  14. 14.

    Cecchetto G, Alaggio R, Bisogno G, Virgone C, Dall’Igna P, Terenziani M, Boldrini R, D’Onofrio V, Ferrari A, Bernini G. Sex cord-stromal tumors of the testis in children. A clinicopathologic report from the Italian TREP project. J Pediatr Surg. 2010;45:1868–73.

    Article  PubMed  Google Scholar 

  15. 15.

    • Cecchetto G, Ferrari A, Bernini G, Alaggio R, Collini P, Virgone C, Terenziani M, Dall’igna P, Cozza R, Conte M, Bisogno G. Sex cord stromal tumors of the ovary in children: a clinicopathological report from the Italian TREP project. Pediatr Blood Cancer. 2011;56:1062–7. This article describes the clinical features and outcome of a very rare pediatric malignancy, highlighting the importance of co-operative group registries to better define these rare tumors.

  16. 16.

    Bisogno G, Soloni P, Conte M, Podda M, Ferrari A, Garaventa A, Luksch R, Cecchetto G. Esthesioneuroblastoma in pediatric and adolescent age. A report from the TREP project in cooperation with the Italian Neuroblastoma and Soft Tissue Sarcoma Committees. BMC Cancer. 2012;12:117.

    Article  PubMed Central  PubMed  Google Scholar 

  17. 17.

    Virgone C, Cecchetto G, Alaggio R, Ferrari A, Bisogno G, Conte M, Inserra A, Fagnani AM, Indolfi P, Salfi N, Dall’Igna P. Appendiceal neuroendocrine tumours in childhood: Italian TREP project. J Pediatr Gastroenterol Nutr. 2014;58(3):333–8.

    Article  PubMed  Google Scholar 

  18. 18.

    Ferrari A, Bisogno G, Cecchetto G, Santinami M, Maurichi A, Bono A, Vajna De Pava M, Pierani P, Bertolini P, Rossi CR, De Salvo GL. Cutaneous melanoma in children and adolescents: the Italian rare tumors in pediatric age project experience. J Pediatr. 2014;164:376–82.

    Article  PubMed  Google Scholar 

  19. 19.

    Chiaravalli S, Guzzo M, Bisogno G, De Pasquale MD, Migliorati R, De Leonardis F, Collini P, Casanova M, Cecchetto G, Ferrari A. Salivary gland carcinomas in children and adolescents: the Italian TREP project experience. Pediatr Blood Cancer. 2014;61:1961–8.

    Article  PubMed  Google Scholar 

  20. 20.

    Dall’Igna P, Virgone C, De Salvo GL, Bertorelle R, Indolfi P, De Paoli A, Buffa P, Conte M, Esposito G, Inserra A, Candiotto C, D’Onofrio V, Boldrini R, Ferrari A, Bisogno G, Alaggio R, Cecchetto G. Adrenocortical tumors in Italian children: analysis of clinical characteristics and P53 status. Data from the national registries. J Pediatr Surg. 2014;49(9):1367–71.

    Article  PubMed  Google Scholar 

  21. 21.

    Brecht IB, Graf N, Schweinitz Dv, Frühwald MC, Bielack SS, Schneider DT. Networking for children and adolescents with very rare tumors: foundation of the GPOH Pediatric Rare Tumor Group. Klin Padiatr. 2009;221(3):181–5.

    Article  CAS  PubMed  Google Scholar 

  22. 22.

    Brecht IB, Bremensdorfer C, Schneider DT, Frühwald MC, Offenmüller S, Mertens R, Vorwerk P, Koscielniak E, Bielack SS, Benesch M, Hero B, Graf N, von Schweinitz D, Kaatsch P. Rare malignant pediatric tumors registered in the German Childhood Cancer Registry 2001-2010. Pediatr Blood Cancer. 2014;61(7):1202–9.

    Article  PubMed  Google Scholar 

  23. 23.

    Balcerska A, Godziński J, Bień E, Stachowicz-Stencel T, Sulka W, Rapała M, Izycka-Swieszewska E, Perek-Polnik M, Drogosiewicz M, Perek D, Kurylak A, Wysocki M, Madziara W, Bohosiewicz J, Kuźmicz M, Krawczuk-Rybak M, Nurzyńska-Flak J, Kowalczyk JR, Rybczyńska A, Wachowiak J, Pietras W, Kazanowska B, Chybicka A, Sopyło B, Matysiak M, Klekawka T, Balwierz W, Zalewska-Szewczyk B, Bodalski J, Pobudejska A, Sońta-Jakimczyk D, Peregud-Pogorzelski J, Fydryk J, Lapińska-Szumczyk S, Emerich J, Mańkowski P, Jankowski A, Woźniak W. Rare tumours–are they really rare in the Polish children population? Przegl Lek. 2004;61(Suppl 2):57–61.

    PubMed  Google Scholar 

  24. 24.

    Stachowicz-Stencel T, Bien E, Balcerska A, Godzinski J, Synakiewicz A, Perek-Polnik M, Kurylak A, Pietras W, Kuzmicz M, Mizia-Malarz A, Rybczynska A, Nurzynska-Flak J. Diagnosis and treatment of renal cell carcinoma in children: a report from the Polish pediatric rare tumor study group. Klin Padiatr. 2011;223(3):138–41.

    Article  CAS  PubMed  Google Scholar 

  25. 25.

    Stachowicz-Stencel T, Bien E, Balcerska A, Godzinski J, Synakiewicz A, Madziara W, Perek-Polnik M, Peregud-Pogorzelski J, Pietras W, Pobudejska A, Kurylak A, Mankowski P. Thymic carcinoma in children: a report from the Polish Pediatric Rare Tumors Study. Pediatr Blood Cancer. 2010;54(7):916–20.

    Article  PubMed  Google Scholar 

  26. 26.

    Bien E, Stachowicz-Stencel T, Balcerska A, Godzinski J, Kazanowska B, Perek-Polnik M, Madziara W, Rybczynska A, Kurylak A, Zalewska-Szewczyk B, Peregud-Pogorzelski J. Angiosarcoma in children—still uncontrollable oncological problem. The report of the Polish Paediatric Rare Tumours Study. Eur J Cancer Care (Engl). 2009;18(4):411–20.

    Article  CAS  Google Scholar 

  27. 27.

    Bien E, Stachowicz-Stencel T, Godzinski J, Balcerska A, Izycka-Swieszewska E, Kazanowska B, Madziara W, Perek-Polnik M, Mankowski P, Nurzynska-Flak J, Rybczynska A, Prokurat A, Oncological Centers of the Polish Pediatric Solid Tumors Study Group. Retrospective multi-institutional study on hemangiopericytoma in Polish children. Pediatr Int. 2009;51(1):19–24.

    Article  PubMed  Google Scholar 

  28. 28.

    Reguerre Y, Lacour B, Andre N, et al. Epidemiology and management of rare paediatric tumours within the framework of the French Society for Children Cancer. Bull Cancer. 2010;97:1041–5.

    CAS  PubMed  Google Scholar 

  29. 29.

    Rod J, Orbach D, Verité C, Coze C, Stephan JL, Varlet F, Thomas-de-Montpreville V, Reguerre Y, Besse B, Sarnacki S. Surgical management of thymic epithelial tumors in children: lessons from the French Society of Pediatric Oncology and review of the literature. Pediatr Blood Cancer. 2014;61(11):1910–5.

    Article  CAS  PubMed  Google Scholar 

  30. 30.

    Bisogno G, Ferrari A, Bien E, Brecht IB, Brennan B, Cecchetto G, Godzinski J, Orbach D, Reguerre Y, Stachowicz-Stencel T, Schneider DT. Rare cancers in children—the EXPeRT Initiative: a report from the European Cooperative Study Group on Pediatric Rare Tumors. Klin Padiatr. 2012;224(6):416–20.

    Article  CAS  PubMed  Google Scholar 

  31. 31.

    • Bien E1, Godzinski J, Dall’igna P, Defachelles AS, Stachowicz-Stencel T, Orbach D, Bisogno G, Cecchetto G, Warmann S, Ellerkamp V, Brennan B, Balcerska A, Rapala M, Brecht I, Schneider D, Ferrari A. Pancreatoblastoma: a report from the European cooperative study group for paediatric rare tumours (EXPeRT). Eur J Cancer. 2011;47(15):2347–52. This article describes the collective experience on Pancratoblastoma through the EXPeRT initiative.

  32. 32.

    Bisogno G, Brennan B, Orbach D, Stachowicz-Stencel T, Cecchetto G, Indolfi P, Bien E, Ferrari A, Dommange-Romero F. Treatment and prognostic factors in pleuropulmonary blastoma: an EXPeRT report. Eur J Cancer. 2014;50(1):178–84.

    Article  PubMed  Google Scholar 

  33. 33.

    Ribeiro RC, Sandrini Neto RS, Schell MJ, Lacerda L, Sambaio GA, Cat I. Adrenocortical carcinoma in children: a study of 40 cases. J Clin Oncol. 1990;8(1):67–74.

    CAS  PubMed  Google Scholar 

  34. 34.

    Michalkiewicz E, Sandrini R, Figueiredo B, Miranda EC, Caran E, Oliveira-Filho AG, Marques R, Pianovski MA, Lacerda L, Cristofani LM, Jenkins J, Rodriguez-Galindo C, Ribeiro RC. Clinical and outcome characteristics of children with adrenocortical tumors: a report from the International Pediatric Adrenocortical Tumor Registry. J Clin Oncol. 2004;22(5):838–45.

    Article  CAS  PubMed  Google Scholar 

  35. 35.

    Malkin D, Li FP, Strong LC, Fraumeni JF Jr, Nelson CE, Kim DH, Kassel J, Gryka MA, Bischoff FZ, Tainsky MA, et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science. 1990;250(4985):1233–8.

    Article  CAS  PubMed  Google Scholar 

  36. 36.

    Figueiredo BC, Sandrini R, Zambetti GP, Pereira RM, Cheng C, Liu W, Lacerda L, Pianovski MA, Michalkiewicz E, Jenkins J, Rodriguez-Galindo C, Mastellaro MJ, Vianna S, Watanabe F, Sandrini F, Arram SB, Boffetta P, Ribeiro RC. Penetrance of adrenocortical tumours associated with the germline TP53 R337H mutation. J Med Genet. 2006;43(1):91–6.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  37. 37.

    Ribeiro RC, Sandrini F, Figueiredo B, Zambetti GP, Michalkiewicz E, Lafferty AR, DeLacerda L, Rabin M, Cadwell C, Sampaio G, Cat I, Stratakis CA, Sandrini R. An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma. Proc Natl Acad Sci USA. 2001;98(16):9330–5.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  38. 38.

    • Ribeiro RC, Pinto EM, Zambetti GP, Rodriguez-Galindo C. The International Pediatric Adrenocortical Tumor Registry initiative: contributions to clinical, biological, and treatment advances in pediatric adrenocortical tumors. Mol Cell Endocrinol. 2012;351(1):37–43. This article describes the International Adrenocortical tumor registry and outlines the clinical features, outcome and biology of adrenocortical carcinomas.

  39. 39.

    • Pinto EM1, Ribeiro RC, Figueiredo BC, Zambetti GP. TP53-associated pediatric malignancies. Genes Cancer. 2011;2(4):485–90. This article describes the biology of adrenocortical tumors and the TP53 mutations identified through the IPACTR.

  40. 40.

    Dehner LP. Pleuropulmonary blastoma is The pulmonary blastoma of childhood. Semin Diagn Pathol. 1994;11(2):144–51.

    CAS  PubMed  Google Scholar 

  41. 41.

    Manivel JC, et al. Pleuropulmonary blastoma. The so-called pulmonary blastoma of childhood. Cancer. 1988;62(8):1516–26.

    Article  CAS  PubMed  Google Scholar 

  42. 42.

    Dishop MK, Kuruvilla S. Primary and metastatic lung tumors in the pediatric population: a review and 25-year experience at a large children’s hospital. Arch Pathol Lab Med. 2008;132(7):1079–103.

    PubMed  Google Scholar 

  43. 43.

    • Messinger YH, Stewart DR, Priest JR, et al. Pleuropulmonary blastoma: A report on 350 central pathology-confirmed pleuropulmonary blastoma cases by the International Pleuropulmonary Blastoma Registry. Cancer. 2015;121:276–85. This article describes the clinical features, progression and outcome of the largest number of pathologically confirmed PPB.

  44. 44.

    Hill DA, et al. Type I pleuropulmonary blastoma: pathology and biology study of 51 cases from the international pleuropulmonary blastoma registry. Am J Surg Pathol. 2008;32(2):282–95.

    Article  PubMed  Google Scholar 

  45. 45.

    Priest JR, et al. Pleuropulmonary blastoma: a marker for familial disease. J Pediatr. 1996;128(2):220–4.

    Article  CAS  PubMed  Google Scholar 

  46. 46.

    • Doros L, Schultz KA, Stewart DR, et al. DICER1-related disorders. In: Pagan RA, Adam MP, Ardinger HH, Bird TD, Dolan CR, Fong CT, Smith RJH, Stephens K, editors. GeneReviews®. Seattle, WA: University of Washington; 2014. This article describes the tumors in the DICER-1 family.

  47. 47.

    Hill DA, et al. DICER1 mutations in familial pleuropulmonary blastoma. Science. 2009;325(5943):965.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  48. 48.

    Pugh TJ, et al. Exome sequencing of pleuropulmonary blastoma reveals frequent biallelic loss of TP53 and two hits in DICER1 resulting in retention of 5p-derived miRNA hairpin loop sequences. Oncogene. 2014;33(45):5295–302.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  49. 49.

    Schultz KA, et al. Judicious DICER1 testing and surveillance imaging facilitates early diagnosis and cure of pleuropulmonary blastoma. Pediatr Blood Cancer. 2014;61(9):1695–7.

    Article  PubMed Central  PubMed  Google Scholar 

  50. 50.

    • Schultz KA, Pacheco MC, Yang J, Williams GM, Messinger Y, Hill DA, Dehner LP, Priest JR. Ovarian sex cord-stromal tumors, pleuropulmonary blastoma and DICER1 mutations: a report from the International Pleuropulmonary Blastoma Registry. Gynecol Oncol. 2011;122(2):246–50. This article describes the findings from the PPB registry, and found that ovarian sex cord stromal tumors are a manifestation of familial PPB syndrome and may be the initial clinical presentation of DICER-1 mutations in a family.

  51. 51.

    Schwartz BE1, Hofer MD, Lemieux ME, Bauer DE, Cameron MJ, West NH, Agoston ES, Reynoird N, Khochbin S, Ince TA, Christie A, Janeway KA, Vargas SO, Perez-Atayde AR, Aster JC, Sallan SE, Kung AL, Bradner JE, French CA. Differentiation of NUT midline carcinoma by epigenomic reprogramming. Cancer Res. 2011;71(7):2686–96. This article showed that restoration of chromatin acetylation by histone deactylase inhibitors produced significant growth inhibition, paving the way for targeted therapy for NUT midline carcinoma.

  52. 52.

    Bauer DE, Mitchell CM, Strait KM, Lathan CS, Stelow EB, Lüer SC, Muhammed S, Evans AG, Sholl LM, Rosai J, Giraldi E, Oakley RP, Rodriguez-Galindo C, London WB, Sallan SE, Bradner JE, French CA. Clinicopathologic features and long-term outcomes of NUT midline carcinoma. Clin Cancer Res. 2012;18(20):5773–9.

    Article  PubMed Central  PubMed  Google Scholar 

  53. 53.

    Chau NG, Mitchell CM, Aserlind A, Grunfeld N, Kaplan L, DE Bauer, Lathan CS, Rodriguez-Galindo C, Hurwitz S, Tishler RB, Haddad RI, Sallan SE, Bradner JE, French CA. Aggressive treatment and survival outcomes in NUT midline carcinoma (NMC) of the head and neck (HN). J Clin Oncol. 2014;32:5s (suppl; abstr 6057).

    Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Farzana Pashankar.

Additional information

This article is part of the Topical Collection on Hematology/Oncology.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Pashankar, F., Bisogno, G., Ribeiro, R. et al. The Role of Registries and Tumor Banking in Rare Pediatric Tumors. Curr Pediatr Rep 3, 128–136 (2015). https://doi.org/10.1007/s40124-015-0077-9

Download citation

Keywords

  • Rare tumors
  • Registry
  • TREP
  • EXPeRT
  • CCRN